Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment

Diabetes

Volumn 46, Issue 3, 1997, Pages 481-487

  Rossing, Peter ^a   Tarnow, Lise ^a   Boelskifte, Søren ^a   Jensen, Berit R ^a   Nielsen, Flemming S ^a   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LISINOPRIL; NISOLDIPINE;

ADULT; AMBULATORY MONITORING; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; EDEMA; ENZYME IMMUNOASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEART PALPITATION; HUMAN; HYPERTENSION; HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NAUSEA; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 0031051404     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.3.481     Document Type: Article

References (50)

1. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes meilitus. Kidney Int 19:410-415, 1981
2. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
3. Mogensen CE: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 36:383-388, 1976
4. Rossing P, Hommel E, Smidt UM, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715-719, 1993
5. Parving H-H, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy. Br Med J 297:1086-1091, 1988
6. Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339-343, 1992
7. Lewis E, Hunsicker L, Bain R, Rhode R: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
8. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i: 1175-1179, 1983
9. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688, 1982
10. Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443-1447, 1987
11. Rossing P, Hommel E, Smidt UM, Parving H-H: Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 45 (Suppl. 45):S145-S149, 1994
12. Rossing P, Hommel E, Smidt UM, Parving H-H: Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 37:511-516, 1994
13. Apperloo AJ, de Zeeuw D, de Jong PE: Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int 45 (Suppl. 45):S174-S178, 1994
14. Parving H-H, Rossing P: Calcium antagonists and the diabetic hypertensive patient. Am J Kidney Dis 21 (Suppl. 3):47-52, 1993
15. White WB, Pickering TG, Morganroth J, James GD, McCabe EJ, Moucha O, Hunter H: A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 4:890-896, 1991
16. Bröchner-Mortensen J, Rödbro P: Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36:35-45, 1976
17. Bröchner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30:271-274, 1972
18. Ladegaard-Pedersen HJ: Measurement of extracellular volume and renal clearance by a single injection of insulin. Scand J Clin Lab Invest 29:145-153, 1972
19. Feldt-Rasmussen B, Dinesen B, Deckert M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-544, 1985
20. Kofoed-Enevoldsen A, Jensen K, Beck TC: Measuring urinary IgG and IgQ, excretion (Letter). Clin Chem 37:1136, 1991
21. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
22. Jensen T, Deckert M, Dawnay A, Feldt-Rasmussen B: Micro-ELISA for the quantitation of human urinary and serum retinol-binding protein. Diabetes Res 10:93-95, 1989
23. Isaksson B: Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 33:4-5, 1980
24. Maroni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58-65, 1985
25. Norgaard K, Jensen T, Christensen P, Feldt-Rasmussen B: A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension. Blood Pressure 2:301-308, 1993
26. Neutel JM, Smith DHG, Ram CVS, Kaplan NM, Papademetriou V, Pagan TC, Lefkowitz MP, Kazempour MK, Weber MA: Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. Am J Med 94:181-187, 1993
27. White WB: Blood pressure load and target organ effects in patients with essential hypertension. J Hypertens 9 (Suppl. 8):S39-S41, 1991
28. Schmilz A, Mau Pedersen M, Hansen KW: Blood pressure by 24-h ambulatory recordings in type n (non-insulin-dependent) diabetics. Relationship to urinary albumin excretion. Diabetes Metab 17:301-307, 1991
29. Demaire BK, Bakris GL: Effects of different classes of calcium antagonist on proteinuria in diabetic subjects. Ann Intern Med 113:987-988, 1990
30. Bretzel RG, Bollen CC, Maeser E, Federtin KF: Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients. Am J Kidney Dis 6:53-64, 1993
31. Weidmann P, Boehlen LM, de Courten M, Ferrari P: Antihypertensive therapy in diabetic patients. J Hum Hypertens 6:S23-S36, 1992
32. Epstein M: Calcium antagonists should continue to be used for first-line treatment of hypertension. Arch Intern Med 155:2150-2156, 1995
33. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 302:210-216, 1991
34. Chan JCN, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R: Comparison of enalapril and nifedipine in treating non-insulin-dependent diabetics associated with hypertension: one-year analysis. Br Med J 305:981-985, 1992
35. O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH: Comparison of the effects of an angiotensin-converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randemised double-blind study. J Hum Hypertens 7:333-339, 1993
36. Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, Endresen L, Djøseland O, Berg K: Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin-dependent diabetics with nephropathy. J Intern Med 229:163-170, 1991
37. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short- and long-term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
38. Morelli E, Loon N, Meyer TW, Peters W, Myers BD: Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39:76-82, 1990
39. Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N: Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats. Biochem Med Metab Biol 45:119-131, 1991
40. Shultz PJ, Raij L: Inhibition of human mesangial cell proliferation by calcium channel blockers. Hypertension 15:1-76-1-80, 1990
41. Anderson S: Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass. Hypertension 17:288-295, 1991
42. Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD: Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int 43:808-814, 1993
43. 2+ channels. Kidney Int 49:868-879, 1996
44. Peterson JC, Adler S, Burkart JM, Greene T, Herbert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. Modification of diet in renal disease study. Ann Intern Med 123:754-762, 1995
45. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving H-H: Increased glomerular nitration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 47:1726-1731, 1995
46. Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica D, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA, Bolten WK: Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int 45 (Suppl. 45):S150-S155, 1994
47. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
48. Maki DD, Ma JZ, Louis TA, Kasiske BL: Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 155:1073-1080, 1995
49. Modification of Diet in Renal Disease Study Group, Levey AS, Gassman J, Hall PM, Walker WG: Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. J Am Soc Nephrol 1:1087-1094, 1991
50. Bakris GL, Copley JB, Vicknair N, Leugans S: Effect of nondihydropyridine calcium antagonists (NDCAs) on progression of nephropathy from non-insulin-dependent diabetes (NTDDM):a five-year follow-up study (Abstract). J Am Soc Nephrol 6:446, 1995